Evidence map›Paper›PMID 30174759›Full record

ArticleThe EPMA journal2018

Biorepository and integrative genomics initiative: designing and implementing a preliminary platform for predictive, preventive and personalized medicine at a pediatric hospital in a historically disadvantaged community in the USA.

Rony Jose, Robert Rooney, Naga Nagisetty, Robert Davis, David Hains

Abstract read
In one paragraph

Article in The EPMA journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genes · 2024
    Article
  5. Article
  6. Standard operating procedures for biobank in oncology.Frontiers in molecular biosciences · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rony Jose1Center for Biomedical Informatics, Department of Pediatrics, University of Tennessee Health Science Center, 50 N Dunlap, Room 487R, Memphis, TN 38103 USA.ORCID 0000-0001-9539-2198
Robert Rooney2Department of Pediatrics, Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, 50 N. Dunlap, Room 366R, Memphis, TN 38103 USA.
Naga Nagisetty3Department of Pediatrics, University of Tennessee Health Science Center, 50 N Dunlap, Room 301R, Memphis, TN 38103 USA.
Robert Davis1Center for Biomedical Informatics, Department of Pediatrics, University of Tennessee Health Science Center, 50 N Dunlap, Room 487R, Memphis, TN 38103 USA.
David Hains4Department of Pediatrics, University of Tennessee Health Science Center, Center for Innate Immunity Translational Research, Children's Foundation Research Institute at Le Bonheur Children's Hospital, 50 N Dunlap, Room 365R, Memphis, TN 38103 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current healthcare is evolving to emphasize cost-effective care by leveraging results and outcomes of genomic and other advanced research efforts in clinical care and preventive health planning. Through a collaborative effort between the University of Tennessee Health Science Center (UTHSC) and Le Bonheur Children's Hospital (LBCH), the Biorepository and Integrative Genomics (BIG) Initiative was established to set up a pediatric-based DNA biorepository that can serve as a foundation for successful development of delivery platforms for predictive, preventive, and personalized medical services in Memphis, Tennessee, a historically disadvantaged community in the USA. In this paper, we describe the steps that were followed to establish the biorepository. We focused on domains that are essential for implementation of a biorepository for genomic research as an initial goal and identified patient consent, DNA extraction, storage and dissemination, and governance as essential components. Specific needs in each of these domains were addressed by respective solutions developed by multidisciplinary teams under the guidance of a governance model that involved experts from multiple hospital arenas and community members. The end result was the successful launch of a large-scale DNA biorepository, with patient consent greater than 75% in the first year. Our experience highlights the importance of performing pre-design research, needs assessment, and designing an ethically vetted plan that is cost-effective, easy to implement, and inclusive of the community that is served. We believe this biorepository model, with appropriate tailoring according to organizational needs and available resources, can be adopted and successfully applied by other small- to mid-sized healthcare organizations.

Indexed as

BiobankCommunityIntegrative genomics initiativePediatricsPredictive preventive personalized medicine

Identifiers

PMID30174759
PMCPMC6107450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.